Table 2.
Baseline characteristics of 219 HIV-infected patients with prevalent TB, incident TB, and no TB.
| Characteristics | Prevalent TB (unrecognized) (n = 6) | Incident TB (n = 8) | No TB (n = 205) |
|---|---|---|---|
| Age (yrs), mean (SD) | 38.5 (5.3) | 38.3 (9.2) | 36.4 (8.2) |
| Gender (Female) (%) | 4 (67) | 6 (75) | 143 (70) |
| BMI (kg/m2), median (IQR) | 18.8 (16.6–19.7)* | 19.1 (17.9–21.2)** | 22.8 (20.4–25.7) |
| CD4 counts (cell/μL), median (IQR) | 131 (60–168) | 103 (23–140) | 131 (67–172) |
| Haemoglobin (g/dL), mean (SD) | 11.9 (1.9) | 10.5 (1.4)** | 12.4 (1.9) |
| C-reactive protein (mg/dL), median (IQR) | 24.9 (11.6–31.5)** | 19.4 (3.9–51.3)* | 2.2 (1.0–6.0) |
| TST positive at ART start (%) | 4 (67) | 1 (25) | 59 (30) |
ART: antiretroviral therapy; BMI, body mass index; IQR: interquartile range; SD: standard deviation; TB: tuberculosis; TST: tuberculin skin test.
P-values: *P < .05, **P < .001 compared with the no TB group.